Earth Science Tech Acquires Meduvo, Expanding Pharmacy Network to 34 U.S. Jurisdictions

Earth Science Tech, Inc. (OTC: ETST) has announced the acquisition of Meduvo LLC, a compounding pharmacy based in La Verne, California. This strategic move establishes a West Coast operational hub and expands the company's pharmacy network to 34 U.S. jurisdictions, marking a significant step in its mission to build a vertically integrated healthcare platform.

Meduvo currently operates from a 2,000-square-foot facility and specializes in compounding and dispensing non-sterile medications. With the acquisition, Earth Science Tech is initiating facility upgrades designed to meet sterility requirements, with management targeting full regulatory certification for sterile compounding by the end of 2028. This forward-looking approach underscores the company's commitment to expanding its capabilities and meeting evolving healthcare needs.

The acquisition is part of Earth Science Tech's broader strategy to create a seamless integration of patient care, from consultation to fulfillment. By combining compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment, the company aims to enhance patient outcomes and streamline healthcare delivery. The West Coast presence is expected to bolster the company's distribution capabilities and support its growth trajectory.

Regulatory approvals are pending in additional states as the company pursues nationwide coverage. This expansion into new jurisdictions could have significant implications for patients seeking specialized medications, as well as for healthcare providers looking for reliable compounding services. The move also positions Earth Science Tech to capitalize on the growing demand for personalized medicine.

The company's diversified holding structure supports its healthcare operations with investments in real estate and asset management, as well as a consumer products business. This integrated approach provides a solid foundation for the expansion, potentially leading to increased market share and operational efficiencies.

For investors, this acquisition signals Earth Science Tech's proactive approach to growth and its ability to execute strategic initiatives. The expansion into sterile compounding could open new revenue streams and enhance the company's competitive edge. As the company continues to pursue regulatory approvals and upgrade facilities, stakeholders will be watching closely to see how these developments translate into long-term value.

For more information about Earth Science Tech and its latest updates, visit the company's newsroom at https://ibn.fm/ETST.